LIVE VACCINE FOR GETAH VIRUS INFECTIOUS DISEASE AND TRIPLE LIVE VACCINE FOR JAPANESE ENCEPHALITIS VIRUS, PORCINE PARVOVIRUS AND GETAH VIRUS INFECTIOUS DISEASE

PURPOSE:To obtain the subject live vaccine, composed of a viral liquid prepared by culturing a specific attenuated Getah virus KB/VT strain with an HAL cell and capable of producing an immune antibody capable of providing the persistent immunity, excellent in safety and useful for pregnant pigs, etc...

Full description

Saved in:
Bibliographic Details
Main Authors IZUMIDA AKIHIRO, KODAMA KAZUO, MATSUI OSAMU, KUBOTA MICHIO, ISHIDA YASUHISA
Format Patent
LanguageEnglish
Published 10.05.1994
Edition5
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PURPOSE:To obtain the subject live vaccine, composed of a viral liquid prepared by culturing a specific attenuated Getah virus KB/VT strain with an HAL cell and capable of producing an immune antibody capable of providing the persistent immunity, excellent in safety and useful for pregnant pigs, etc. CONSTITUTION:The objective live vaccine is composed of a viral liquid obtained by subculturing and attenuating a virulent Getah virus strain at a temperature within the range of the proliferation permissible range, culturing the resultant attenuated Getah virus KB/VT strain with an HAL cell.
Bibliography:Application Number: JP19920078581